跳至主要内容
临床试验/NCT02604056
NCT02604056已完成不适用

Ontario Appropriate Prescribing Demonstration Project: Pragmatic, Cluster-Randomized Clinical Trial to Reduce Antipsychotic Medication Prescribing in Long-Term Care Homes

Women's College Hospital0 个研究点目标入组 60 人开始时间: 2015年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
主要终点
Antipsychotic dispensing

研究概览

简要总结

Two arm, pragmatic, cluster-randomized trial, with nursing homes allocated to the full, active intervention (featuring educational outreach offered to each prescriber and team members in the home) or standard quality improvement supports (including online audit and feedback reports for each prescriber in the home). The 'standard' quality improvement supports represent 'usual care' as these are to be launched province-wide; a concurrent control arm with no exposure to a quality improvement intervention is not feasible.

详细描述

The Ministry of Health and Long-Term Care and Ontario Medical Association have initiated a project aiming to improve appropriateness of prescribing in long-term care facilities (aka nursing homes) through integrated educational supports for nursing home prescribers, inter-professional care teams, as well as residents and family members. The first focus of the project is appropriate prescribing of antipsychotic medications. Working with Health Quality Ontario, the policy makers have determined that all prescribers will have the opportunity to review practice reports detailing their prescribing performance for this class of medication (aka audit and feedback).

The primary question of this pragmatic, cluster-randomized trial is: What is the effect of adding educational outreach compared to the 'usual' quality improvement supports (i.e. audit and feedback) on prescribing of antipsychotic medications in long-term care?

Secondary questions include the following:

i. What is the effect of the intervention on acute care utilization (e.g., emergency room) rates? ii. What is the effect of the intervention on incidence of patient clinical outcomes and/or adverse effects associated with antipsychotic medications (e.g., falls, aggressive behaviours)? iii. What is the effect of the interventions on medications that might be used as alternatives to antipsychotic medications (e.g., benzodiazepines)? iv. What is the cost-benefit, focusing on prescribing outcomes?

Process evaluation questions include the following:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Audit + Feedback

Active Comparator

'Usual care' / standard quality improvement supports (including online Audit and Feedback reports for each prescriber in the home)

干预措施: Audit + Feedback (Behavioral)

Audit + Feedback + Educational Outreach

Experimental

'Active/full' intervention (featuring Educational Outreach offered to each prescriber and team members in the home)

干预措施: Audit + Feedback (Behavioral)

Audit + Feedback + Educational Outreach

Experimental

'Active/full' intervention (featuring Educational Outreach offered to each prescriber and team members in the home)

干预措施: Audit + Feedback + Educational Outreach (Behavioral)

结局指标

主要结局

Antipsychotic dispensing

时间窗: 6 months post-intervention

Number of days with antipsychotic prescriptions in the last week (count, range 0 - 7)

次要结局

  • Aggressive behaviour scale(3 and 6 months post-intervention)
  • Benzodiazepine (or sedative) prescribing(3 and 6 months post-intervention)
  • Anti-depressant prescribing(3 and 6 months post-intervention)
  • Pain(3 and 6 months post-intervention)
  • Falls(3 and 6 months post-intervention)
  • Hospitalizations(3 months post-intervention)
  • Acetaminophen prescribing(3 and 6 months post-intervention)
  • Depression(3 and 6 months post-intervention)
  • Antipsychotic prescribing(3 and 6 months post-intervention)
  • Mean Antipsychotic dose(3 and 6 months post-intervention)
  • Difficulty in performing activities(3 and 6 months post-intervention)
  • Emergency Room visits(3 months post-intervention)

研究者

申办方类型
Other
责任方
Sponsor

相似试验